ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) announced today that the Company’s President and Chief Executive Officer, J.J. Finkelstein, will present at the 13th Annual BIO CEO & Investor Conference being held at the Waldorf Astoria Hotel in New York City on February 15th, at 10:30 a.m. Eastern time.
